 The COVID-19 pandemic has disrupted life worldwide, and while vaccines offer relief for high-income countries, they are unlikely to arrive in time for low- and middle-income countries. A study found that treatment with statins and ACEIs, ARBs reduced 28-day mortality in hospitalized COVID-19 patients, with a three-fold reduction in the odds of hospital mortality from combination treatment. Further studies and clinical trials are needed to conclusively show that these drugs save lives. This article was authored by Duke Bitterbeer, Luke Belmans, Miriam Alexander, and others.